Results 221 to 230 of about 46,183 (248)

Arrestin Pathways as Drug Targets

2013
Our growing appreciation of the pluridimensionality of G protein-coupled receptor (GPCR) efficacy, coupled with the phenomenon of orthosteric ligand "bias," offers the prospect of drugs that selectively modulate different aspects of GPCR function for therapeutic benefit.
openaire   +2 more sources

Arrestins

2022
openaire   +1 more source

Cannabinoid 1 (CB1) receptor arrestin subtype‐selectivity and phosphorylation dependence

British Journal of Pharmacology, 2023
Jamie J Manning, Gabriel Rawcliffe, David B Finlay   +2 more
exaly  

Arrestins

2013
Cornelia Walther, Stephen S.G. Ferguson
openaire   +1 more source

True Arrestins and Arrestin-Fold Proteins

2013
Laurence Aubry, Gérard Klein
openaire   +1 more source

β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors

Cell, 2020
Lauren M Slosky, Yushi Bai, Krisztián Tóth   +2 more
exaly  

Arrestins

2006
openaire   +2 more sources

History of arrestins

2022
Vsevolod V. Gurevich, Eugenia V. Gurevich   +1 more
openaire   +1 more source

Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors

Cell, 2017
X Edward Zhou, Yuanzheng He, Parker W de Waal   +2 more
exaly  

β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs

ACS Sensors, 2020
Atsuro Oishi, Julie Dam, Ralf Jockers
exaly